US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,783, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Anti-New York esophageal squamous cell carcino... Read More

US Patent Issued to Millennium Pharmaceuticals on April 14 for "Anti-Clec12A antibodies and uses thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,784, issued on April 14, was assigned to Millennium Pharmaceuticals Inc. (Cambridge, Mass.). "Anti-Clec12A antibodies and uses thereof" wa... Read More

US Patent Issued to Antlera Therapeutics on April 14 for "Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene" (Canadian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,785, issued on April 14, was assigned to Antlera Therapeutics Inc. (Foster City, Calif.). "Method of screening for compounds that inhibit ... Read More

US Patent Issued to R.G.C.C. Holdings on April 14 for "C-met and TMX2 antibodies" (Swiss Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,786, issued on April 14, was assigned to R.G.C.C. Holdings AG (Zug, Switzerland). "C-met and TMX2 antibodies" was invented by Ioannis Papa... Read More

US Patent Issued to Horizon Therapeutics Ireland DAC on April 14 for "Methods for the treatment of thyroid eye disease" (Illinois, California, Puerto Rico Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,787, issued on April 14, was assigned to Horizon Therapeutics Ireland DAC (Dublin). "Methods for the treatment of thyroid eye disease" was... Read More

US Patent Issued to Viridian Therapeutics on April 14 for "Compositions and methods for treatment of thyroid eye disease" (Massachusetts, Puerto Rico Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,788, issued on April 14, was assigned to Viridian Therapeutics Inc. (Waltham, Mass.). "Compositions and methods for treatment of thyroid e... Read More

US Patent Issued to Chugai Seiyaku on April 14 for "Modified antibody constant region" (Japanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,789, issued on April 14, was assigned to Chugai Seiyaku K.K. (Tokyo). "Modified antibody constant region" was invented by Tomoyuki Igawa (... Read More

US Patent Issued to Vivasor on April 14 for "Variant antibody that binds CD38" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,790, issued on April 14, was assigned to Vivasor Inc. (San Diego). "Variant antibody that binds CD38" was invented by Barbara A. Swanson (... Read More

US Patent Issued to EXCELMAB on April 14 for "Bispecific antibody, preparation method therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,791, issued on April 14, was assigned to EXCELMAB INC. (Guangzhou, China). "Bispecific antibody, preparation method therefor and applicati... Read More

US Patent Issued to ELANCO TIERGESUNDHEIT on April 14 for "Monoclonal antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,792, issued on April 14, was assigned to ELANCO TIERGESUNDHEIT AG (Basel, Switzerland). "Monoclonal antibodies and methods of use" was inv... Read More

• ««
• «
• 1792
• 1793
• 1794
• 1795
• 1796
• 1797
• 1798
• 1799
• 1800
• 1801
• »
• »»